NYSE · Drug Manufacturers - Specialty & Generic

Hims Hers Health Inc (HIMS)

$33.78 +6.03%
Add alert
58 In band Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 50$32.03+5.46%
SMA 200$29.64+13.97%
EMA 20$30.62+10.32%

Company profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$7.35B
P/E ratioNone
EPS$-0.09
Beta2.415
Dividend yield0.00%
52-week high$65.30
52-week low$13.74

Insider transactions

ExecutiveTitleActionSharesDate
SCHULTZ, KAREDirectorBuy8,2232026-08-12
PAYNE, CHRISTOPHER DDirectorBuy5452026-08-12
PAYNE, CHRISTOPHER DDirectorBuy8,2232026-08-12
Continue with Google
Unlock insider transactions

Latest news

Bragar Eagel & Squire, P.C. is Investigating Hims & Hers
Bearish GlobeNewswire 3 days ago
HIMS Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. Investors to Contact the Firm
Bearish NewMediaWire 3 days ago
Hims & Hers (NYSE: HIMS) policy chief sells shares under 10b5-1 plan
Somewhat-Bearish Stock Titan 4 days ago

Earnings call transcript

Q2 2026

Hello, everyone. Thank you for joining us and welcome to the Hims & Hers Health Second Quarter 2026 earnings call. I will now turn the conference over to Bill Newby, Director of Investor Relations. Bill, please go ahead.…

Continue with Google
Unlock the earnings call transcript

Options chain

TypeStrikeExpiryVolumeOpen interest
Put$28.002026-08-2111,8994,061
Call$30.002026-08-219,0878,699
Call$32.002026-08-215,4365,146
Continue with Google
Unlock the options chain

Similar stocks in Drug Manufacturers - Specialty & Generic

CGC Canopy Growth Corporation RSI 64 BFRI Biofrontera Inc RSI 75 TLRY Tilray Brands Inc - Class 2 RSI 58 LNTH Lantheus Holdings Inc RSI 42 ACB Aurora Cannabis Inc RSI 73 BCRX Biocryst Pharmaceuticals Inc RSI 49 INM InMed Pharmaceuticals Inc RSI 46 ORGO Organogenesis Holdings Inc - Class A RSI 35 ZTS Zoetis Inc - Class A RSI 57 AQST Aquestive Therapeutics Inc RSI 52
Free forever

RSI alerts for HIMS

Get an email the moment Hims Hers Health Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 23 August 2026 at 11:49 PM EDT